SOX2 and glioma: In glioma therapy, the miR-145/SOX2-Wnt/β-catenin axis plays a key role in DMC-mediated glioma stem cell (GSC) inhibition, and upregulation of miR-145 can effectively enhance the effect of DMC against GSC; therefore, this may be a new therapeutic target for GSC resistance [202].